Beurs gesloten -
Bombay S.E.
12:00:49 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
229,4
INR
|
-1,71%
|
|
+3,71%
|
+34,34%
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
51.703
|
33.626
|
8.369
|
17.089
|
28.966
|
19.559
|
Bedrijfswaarde
1 |
61.052
|
43.080
|
19.658
|
29.078
|
43.237
|
38.560
|
K/w-verhouding
|
33,4
x
|
16
x
|
4,76
x
|
-10,3
x
|
161
x
|
-65,6
x
|
Dividendrendement
|
-
|
0,1%
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3
x
|
1,63
x
|
0,41
x
|
0,89
x
|
1,35
x
|
0,81
x
|
Bedrijfswaarde/omzet
|
3,54
x
|
2,09
x
|
0,96
x
|
1,52
x
|
2,02
x
|
1,6
x
|
Bedrijfswaarde/EBITDA
|
15,3
x
|
7,49
x
|
3,92
x
|
11,7
x
|
14,9
x
|
11,7
x
|
Bedrijfswaarde/FCF
|
-149
x
|
-53,1
x
|
85
x
|
-338
x
|
-27,5
x
|
-18,9
x
|
FCF Yield
|
-0,67%
|
-1,88%
|
1,18%
|
-0,3%
|
-3,64%
|
-5,3%
|
Price to Book
|
1,01
x
|
0,63
x
|
0,15
x
|
0,3
x
|
0,52
x
|
0,34
x
|
Aantal aandelen (in duizenden)
|
161.394
|
161.394
|
156.863
|
156.783
|
156.783
|
156.783
|
Referentieprijs
2 |
320,4
|
208,4
|
53,35
|
109,0
|
184,8
|
124,8
|
Datum van publicatie
|
27/08/18
|
29/08/19
|
1/09/20
|
25/06/21
|
6/09/22
|
4/09/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
17.230
|
20.586
|
20.436
|
19.120
|
21.407
|
24.129
|
EBITDA
1 |
3.987
|
5.751
|
5.021
|
2.480
|
2.899
|
3.303
|
Bedrijfsresultaat (EBIT)
1 |
2.797
|
4.236
|
3.463
|
709,1
|
1.185
|
1.517
|
Operationele Marge
|
16,23%
|
20,58%
|
16,95%
|
3,71%
|
5,54%
|
6,29%
|
Resultaat voor belastingen (EBT)
1 |
2.308
|
3.088
|
2.221
|
-650,3
|
-42,5
|
-545,9
|
Nettowinst (verlies)
1 |
1.546
|
2.103
|
1.803
|
-1.651
|
180,1
|
-298
|
Nettomarge
|
8,97%
|
10,22%
|
8,82%
|
-8,64%
|
0,84%
|
-1,24%
|
WPA
2 |
9,577
|
13,03
|
11,20
|
-10,53
|
1,149
|
-1,901
|
Free Cash Flow
1 |
-409,6
|
-812
|
231,4
|
-85,95
|
-1.574
|
-2.043
|
FCF-marge
|
-2,38%
|
-3,94%
|
1,13%
|
-0,45%
|
-7,35%
|
-8,47%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
4,61%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
12,83%
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
0,2000
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/08/18
|
29/08/19
|
1/09/20
|
25/06/21
|
6/09/22
|
4/09/23
|
Fiscaal tijdperk: Maart |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Omzet
1 |
4.686
|
5.293
|
5.507
|
4.589
|
5.621
|
5.690
|
5.406
|
6.140
|
6.398
|
6.186
|
EBITDA
1 |
626,1
|
883,6
|
1.006
|
992,3
|
1.085
|
219,9
|
882,9
|
786
|
1.139
|
514,4
|
Bedrijfsresultaat (EBIT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operationele Marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-160,7
|
-1.350
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
-3,43%
|
-25,51%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
WPA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/02/21
|
11/05/21
|
12/08/21
|
28/10/21
|
3/02/22
|
10/05/22
|
9/08/22
|
11/11/22
|
11/02/23
|
23/05/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
9.350
|
9.453
|
11.289
|
11.989
|
14.271
|
19.001
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,345
x
|
1,644
x
|
2,248
x
|
4,835
x
|
4,923
x
|
5,752
x
|
Free Cash Flow
1 |
-410
|
-812
|
231
|
-86
|
-1.574
|
-2.043
|
ROE (netto-inkomsten/eigen vermogen)
|
3,12%
|
4,01%
|
3,24%
|
-2,89%
|
0,32%
|
-0,52%
|
ROA (netto-inkomsten/totale activa)
|
2,54%
|
3,65%
|
2,78%
|
0,54%
|
0,87%
|
1,05%
|
Totale activa
1 |
60.878
|
57.623
|
64.772
|
-307.849
|
20.673
|
-28.424
|
Nettoactief per aandeel
2 |
316,0
|
333,0
|
366,0
|
363,0
|
354,0
|
371,0
|
Cashflow per aandeel
2 |
4,060
|
4,730
|
7,770
|
15,50
|
7,030
|
8,410
|
Capex
1 |
2.165
|
3.081
|
4.086
|
3.660
|
4.638
|
5.741
|
Capex/omzet
|
12,56%
|
14,97%
|
19,99%
|
19,14%
|
21,67%
|
23,79%
|
Datum van publicatie
|
27/08/18
|
29/08/19
|
1/09/20
|
25/06/21
|
6/09/22
|
4/09/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|